IRVINE, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE,
Inc. (NASDAQ: BIOL), the global leader in dental lasers,
announced today its Waterlase Pediatric Dental Academy (WPDA),
for Waterlase pediatric dentists. The WPDA will provide clinicians
with an immersive training experience through peer-led learning,
best practice sharing and on-going mentorship, to ensure optimal
integration of Waterlase technology into clinical practices.
"Pediatric dentists are actively seeking new ways to treat their
young patients in a more gentle and holistic manner than
traditional dental equipment offers; and we saw this as an
opportunity to live out our mission of advancing dentistry in this
community," said John Beaver,
President and CEO of BIOLASE. "From minimally invasive tongue-tie
releases for infants and toddlers to no-shot cavity preparations,
Waterlase is the perfect addition to any pediatric practice to help
kids feel more comfortable in the chair, and hopefully, instill
healthy practices in oral care for life."
As part of the WPDA, members will have access to both
virtual and in-person continuing education opportunities, as well
as clinical support sessions to review cases, best practice
techniques and exclusive Web content. The Academy leadership
includes several experienced pediatric dentists, including Dr.
Ben Curtis, who serves as the
Executive Director, Drs. Cherish
Leung, Linda Murzyn-Dantzer
and Reena Kuba.
"I believe dental lasers are the future of dentistry, and I am
thrilled to be part of an academy that allows pediatric dentists
the opportunity to collaborate, learn and train with Waterlase,"
said Dr. Ben Curtis. "My practice
has greatly benefited from the diverse therapies the Waterlase
laser provides, from limiting the time patients are in the chair to
allowing for minimally invasive treatments that take the fear out
of their visit. I'm eager for those in the pediatric dentistry
community to experience these same results."
Waterlase all-tissue dental lasers afford pediatric clinicians
the ability to remove tooth decay gently and precisely, with less
aerosols, less vibration, and little-to-no anesthesia. It can also
perform soft tissue procedures with less blood and faster healing
than traditional scalpel and suture methods. The versatility of
Waterlase combined with the on-going education, training and
clinical fellowship of the WPDA, allows any pediatric clinician to
integrate the technology and offer laser dentistry to their patient
base. The formation of the WPDA comes on the heels of the recently
established specialty academies, the Waterlase Perio Academy and
Waterlase Endo Academy.
Learn more about the Waterlase Pediatric Dental Academy at
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and medicine.
BIOLASE's products advance the practice of dentistry and medicine
for patients and healthcare professionals. BIOLASE's proprietary
laser products incorporate approximately 271 patented and 40
patent-pending technologies designed to provide biologically and
clinically superior performance with less pain and faster recovery
times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 41,200 laser systems to date in
over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at
www.twitter.com/biolaseinc, Instagram at
www.instagram.com/waterlase_laserdentistry, and LinkedIn at
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
View original content to download
SOURCE BIOLASE, Inc.